These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 17643060

  • 1. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A, Janig E, Stumptner C, Fuchsbichler A, Zatloukal K, Denk H.
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [Abstract] [Full Text] [Related]

  • 2. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI, Agorogiannis GI, Papadimitriou A, Hadjigeorgiou GM.
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
    [Abstract] [Full Text] [Related]

  • 3. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK, Paul S.
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [Abstract] [Full Text] [Related]

  • 4. Clusterin and Alzheimer's disease.
    Calero M, Rostagno A, Frangione B, Ghiso J.
    Subcell Biochem; 2005 Apr; 38():273-98. PubMed ID: 15709484
    [Abstract] [Full Text] [Related]

  • 5. Contribution of glutamatergic signaling to nitrosative stress-induced protein misfolding in normal brain aging and neurodegenerative diseases.
    Nakamura T, Gu Z, Lipton SA.
    Aging Cell; 2007 Jun; 6(3):351-9. PubMed ID: 17388798
    [Abstract] [Full Text] [Related]

  • 6. Mechanical stress and formation of protein aggregates in neurodegenerative disorders.
    Hachiya NS, Kozuka Y, Kaneko K.
    Med Hypotheses; 2008 Jun; 70(5):1034-7. PubMed ID: 17910993
    [Abstract] [Full Text] [Related]

  • 7. Modulation of neurodegeneration by molecular chaperones.
    Muchowski PJ, Wacker JL.
    Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of disease II: cellular protein quality control.
    Outeiro TF, Tetzlaff J.
    Semin Pediatr Neurol; 2007 Mar; 14(1):15-25. PubMed ID: 17331880
    [Abstract] [Full Text] [Related]

  • 9. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.
    Foguel D, Silva JL.
    Biochemistry; 2004 Sep 14; 43(36):11361-70. PubMed ID: 15350123
    [Abstract] [Full Text] [Related]

  • 10. Folding proteins in fatal ways.
    Selkoe DJ.
    Nature; 2003 Dec 18; 426(6968):900-4. PubMed ID: 14685251
    [Abstract] [Full Text] [Related]

  • 11. Emerging roles of J proteins in neurodegenerative disorders.
    Gibbs SJ, Braun JE.
    Neurobiol Dis; 2008 Nov 18; 32(2):196-9. PubMed ID: 18760363
    [Abstract] [Full Text] [Related]

  • 12. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K, Higuchi K, Ikeda S.
    Brain Nerve; 2012 Jun 18; 64(6):665-74. PubMed ID: 22647474
    [Abstract] [Full Text] [Related]

  • 13. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
    Naeem A, Fazili NA.
    Cell Biochem Biophys; 2011 Nov 18; 61(2):237-50. PubMed ID: 21573992
    [Abstract] [Full Text] [Related]

  • 14. Quality control against misfolded proteins in the cytosol: a network for cell survival.
    Kubota H.
    J Biochem; 2009 Nov 18; 146(5):609-16. PubMed ID: 19737776
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
    Nakamura T, Lipton SA.
    Cell Death Differ; 2007 Jul 18; 14(7):1305-14. PubMed ID: 17431424
    [Abstract] [Full Text] [Related]

  • 17. Cholesterol involvement in the pathogenesis of neurodegenerative diseases.
    Liu JP, Tang Y, Zhou S, Toh BH, McLean C, Li H.
    Mol Cell Neurosci; 2010 Jan 18; 43(1):33-42. PubMed ID: 19660552
    [Abstract] [Full Text] [Related]

  • 18. Proteopathy: the next therapeutic frontier?
    Walker LC, LeVine H.
    Curr Opin Investig Drugs; 2002 May 18; 3(5):782-7. PubMed ID: 12090553
    [Abstract] [Full Text] [Related]

  • 19. Strategies for the inhibition of protein aggregation in human diseases.
    Bartolini M, Andrisano V.
    Chembiochem; 2010 May 17; 11(8):1018-35. PubMed ID: 20401887
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.